Journal for ImmunoTherapy of Cancer (Nov 2023)

630 EO2401, a new peptide immunotherapy against cancer, in combination with nivolumab, induces a strong and durable immune response in patients from the EOADR1–19/SPENCER study

  • Salvatore Grisanti,
  • Vivek Subbiah,
  • Eric Baudin,
  • Gedske Daugaard,
  • Alfredo Berruti,
  • Jennifer Martinez,
  • Camilo Jimenez,
  • Harm Haak,
  • Jerome Kervevan,
  • Lucie Aubergeon,
  • Chloé Ventujol,
  • Christophe Bonny,
  • Laurent Chene,
  • Joao Gamelas Magalhaes,
  • CWillemien Menke-vander Houven van Oordt,
  • Martin Fassnacht,
  • Jaume Capdevila,
  • Christelle de la Fouchardière,
  • Dan Granberg,
  • Matthias Kroiss,
  • Hélène Toussaint,
  • Camille Belyn,
  • Jean-Michel Paillarse

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0630
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.